Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,165.08
(
0.80%
)
US TECH 100
26,538.40
(
1.85%
)
Dow Jones
49,247.66
(
-0.13%
)
Brent Oil
100.66
(
0.00%
)
Bitcoin
78,201.64
(
0.75%
)
News Focus
News Focus
Post# of 822936
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Roman516

Send PM Follow Ignore
Followers 56
Posts 1780
Boards Moderated 0
Alias Born 05/27/2022

Roman516

Re: HyGro post# 521692

Thursday, 10/13/2022 5:32:27 PM

Thursday, October 13, 2022 5:32:27 PM

Post# of 822936
Who cares about the NVCR Optune pivotal Phase 3 trial results in the high quality peer-reviewed journals. NWBO OS data is valid, and many doctors, scientist and professionals all agree. I see that NVCR stock price is the same as it was in 2019 four years ago with a 0% increase. NWBO stock increased from $0.21 to $0.663 four years ago with a 215% increase. Glad to know many of my friends purchased NWBO four years ago. Looking forward to NWBO approvals and the stock price to increase as well.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News